Surrozen (SRZN) Total Liabilities (2020 - 2026)
Surrozen (SRZN) recorded quarterly Total Liabilities of $398.9 million in Q1 2026, up 39.22% quarter-over-quarter from $286.5 million in Q4 2025, and up 265.4% on a YoY basis from $109.2 million in Q1 2025.
Surrozen (SRZN) Total Liabilities (2020 - 2026) Analysis & Trends
Surrozen's Total Liabilities history runs 7 years deep, the most recent figure standing at $398.9 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 265.4% year-over-year to $398.9 million; the TTM figure through Mar 2026 stood at $398.9 million (up 265.4% YoY), while the FY2025 annual figure was $286.5 million, up 310.17% from the prior year.
- Total Liabilities was $398.9 million for Q1 2026 at Surrozen, up from $286.5 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $398.9 million in Q1 2026 to a low of $6.6 million in Q1 2024.
- Historically, Total Liabilities has averaged $71.7 million across 5 years, with a median of $15.0 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Total Liabilities tumbled 51.1% in 2022, then soared 1558.89% in 2025.
- A 5-year view of Total Liabilities shows it stood at $13.4 million in 2022, then plunged by 39.37% to $8.1 million in 2023, then jumped by 757.54% to $69.8 million in 2024, then jumped by 310.17% to $286.5 million in 2025, then jumped by 39.22% to $398.9 million in 2026.
- The last three Total Liabilities figures came in at $398.9 million (Q1 2026), $286.5 million (Q4 2025), and $117.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 19.51 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 10.44 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 137.56 Mn |
| 10 | Surrozen | 225,877.86 | -106.68 Mn | - | 398.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 398.86 Mn |
| Dec 31, 2025 | 286.49 Mn |
| Sep 30, 2025 | 117.56 Mn |
| Jun 30, 2025 | 55.58 Mn |
| Mar 31, 2025 | 109.16 Mn |
| Dec 31, 2024 | 69.85 Mn |
| Sep 30, 2024 | 42.33 Mn |
| Jun 30, 2024 | 39.01 Mn |
| Mar 31, 2024 | 6.58 Mn |
| Dec 31, 2023 | 8.15 Mn |
| Sep 30, 2023 | 8.44 Mn |
| Jun 30, 2023 | 8.94 Mn |
| Mar 31, 2023 | 11.16 Mn |
| Dec 31, 2022 | 13.43 Mn |
| Sep 30, 2022 | 13.94 Mn |
| Jun 30, 2022 | 14.43 Mn |
| Mar 31, 2022 | 14.99 Mn |
| Dec 31, 2021 | 27.47 Mn |
| Sep 30, 2021 | 26.91 Mn |
| Jun 30, 2021 | 9.90 Mn |